DNA methylation and Rett syndrome

Human Molecular Genetics

Volumn 12, Issue REV. ISS. 2, 2003, Pages

  Kriaucionis, Skirmantas ^a   Bird, Adrian ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; DNA; METHYL CPG BINDING PROTEIN;

CLINICAL FEATURE; DISEASE MODEL; DNA METHYLATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; MALE; MISSENSE MUTATION; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DNA BINDING; RETT SYNDROME; REVIEW;

EID: 0141925713     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg286     Document Type: Review

References (78)

1. Antequera, F. and Bird, A. (1993) Number of CpG islands and genes in human and mouse. Proc. Natl Acad. Sci. USA, 90, 11995-11999.
2. Waterston, R.H., Lindblad-Toh, K., Birney, E., Rogers, J., Abril, J.F., Agarwal, P., Agarwala, R., Ainscough, R., Alexandersson, M., An, P. et al. (2002) Initial sequencing and comparative analysis of the mouse genome. Nature, 420, 520-562.
3. Bird, A.P. and Wolffe, A.P. (1999) Methylation-induced repression - belts, braces, and chromatin. Cell, 99, 451-454.
4. Jaenisch, R. and Bird, A. (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet., 33 (Suppl.), 245-254.
5. Maier, H., Colbert, J., Fitzsimmons, D., Clark, D.R. and Hagman, J. (2003) Activation of the early B-cell-specific mb-1 (Ig-alpha) gene by Pax-5 is dependent on an unmethylated Ets binding site. Mol. Cell. Biol., 23, 1946-1960.
6. Bell, A.C. and Felsenfeld, G. (2000) Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature, 405, 482-485.
7. Hendrich, B. and Bird, A. (1998) Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol., 18, 6538-6547.
8. Prokhortchouk, A., Hendrich, B., Jorgensen, H., Ruzov, A., Wilm, M., Georgiev, G., Bird, A. and Prokhortchouk, E. (2001) The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev., 15, 1613-1618.
9. Hendrich, B., Hardeland, U., Ng, H.H., Jiricny, J. and Bird, A. (1999) The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature, 401, 301-304.
10. Hendrich, B. and Bickmore, W. (2001) Human diseases with underlying defects in chromatin structure and modification. Hum. Mol. Genet., 10, 2233-2242.
11. Amir, R.E., Van, d. V., I, Wan, M., Tran, C.Q., Francke, U. and Zoghbi, H.Y. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet., 23, 185-188.
12. Armstrong, D.D. (2002) Neuropathology of Rett syndrome. Ment. Retard. Dev. Disabil. Res. Rev., 8, 72-76.
13. Glaze, D.G. (2002) Neurophysiology of Rett syndrome. Ment. Retard. Dev. Disabil. Res. Rev., 8, 66-71.
14. Hagberg, B. (2002) Clinical manifestations and stages of Rett syndrome. Ment. Retard. Dev. Disabil. Res. Rev., 8, 61-65.
15. Jellinger, K.A. (2003) Rett syndrome - an update. J. Neural Transm., 110, 681-701.
16. Cass, H., Reilly, S., Owen, L., Wisbeach, A., Weekes, L., Slonims, V., Wigram, T. and Charman, T. (2003) Findings from a multidisciplinary clinical case series of females with Rett syndrome. Dev. Med. Child Neurol., 45, 325-337.
17. Akbarian, S. (2003) The neurobiology of Rett syndrome. Neuroscientist, 9, 57-63.
18. Amir, R., Dahle, E.J., Toriolo, D. and Zoghbi, H.Y. (2000) Candidate gene analysis in Rett syndrome and the identification of 21 SNPs in Xq. Am. J. Med. Genet., 90, 69-71.
19. Cooper, D.N. and Youssoufian, H. (1988) The CpG dinucleotide and human genetic disease. Hum. Genet., 78, 151-155.
20. Couvert, P., Bienvenu, T., Aquaviva, C., Poirier, K., Moraine, C., Gendrot, C., Verloes, A., Andres, C., Le Fevre, A.C., Souville, I. et al. (2001) MECP2 is highly mutated in X-linked mental retardation. Hum. Mol. Genet., 10, 941-946.
21. Watson, P., Black, G., Ramsden, S., Barrow, M., Super, M., Kerr, B. and Clayton-Smith, J. (2001) Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J. Med. Genet., 38, 224-228.
22. Lobo-Menendez, F., Sossey-Alaoui, K., Bell, J.M., Copeland-Yates, S.A., Plank, S.M., Sanford, S.O., Skinner, C., Simensen, R.J., Schroer, R.J. and Michaelis, R.C. (2003) Absence of MeCP2 mutations in patients from the South Carolina autism project. Am. J. Med. Genet., 117B, 97-101.
23. Zappella, M., Meloni, I., Longo, I., Canitano, R., Hayek, G., Rosaia, L., Mari, F. and Renieri, A. (2003) Study of MECP2 gene in Rett syndrome variants and autistic girls. Am. J. Med. Genet., 119B, 102-107.
24. Carney, R.M., Wolpert, C.M., Ravan, S.A., Shahbazian, M., Ashley-Koch, A., Cuccaro, M.L., Vance, J.M. and Pericak-Vance, M.A. (2003) Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr. Neurol., 28, 205-211.
25. Villard, L., Kpebe, A., Cardoso, C., Chelly, P.J., Tardieu, P.M. and Fontes, M. (2000) Two affected boys in a Rett syndrome family: clinical and molecular findings. Neurology, 55, 1188-1193.
26. Ravn, K., Nielsen, J.B., Uldall, P., Hansen, F.J. and Schwartz, M. (2003) No correlation between phenotype and genotype in boys with a truncating MECP2 mutation. J. Med. Genet., 40, e5.
27. Topcu, M., Akyerli, C., Sayi, A., Toruner, G.A., Kocoglu, S.R., Cimbis, M. and Ozcelik, T. (2002) Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy. Eur. J. Hum. Genet., 10, 77-81.
28. Meehan, R.R., Lewis, J.D., McKay, S., Kleiner, E.L. and Bird, A.P. (1989) Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell, 58, 499-507.
29. Lewis, J.D., Meehan, R.R., Henzel, W.J., Maurer-Fogy, I., Jeppesen, P., Klein, F. and Bird, A. (1992) Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell, 69, 905-914.
30. Nan, X., Tate, P., Li, E. and Bird, A. (1996) DNA methylation specifies chromosomal localization of MeCP2. Mol. Cell Biol., 16, 414-421.
31. Nan, X., Meehan, R.R. and Bird, A. (1993) Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucl. Acids Res., 21, 4886-4892.
32. Chandler, S.P., Guschin, D., Landsberger, N. and Wolffe, A.P. (1999) The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemistry, 38, 7008-7018.
33. Ohki, I., Shimotake, N., Fujita, N., Jee, J., Ikegami, T., Nakao, M. and Shirakawa, M. (2001) Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA. Cell, 105, 487-497.
34. Fournier, C., Goto, Y., Ballestar, E., Delaval, K., Hever, A.M., Esteller, M. and Feil, R. (2002) Allele-specific histone lysine methylation marks regulatory regions at imprinted mouse genes. EMBO J., 21, 6560-6570.
35. Fuks, F., Hurd, P.J., Wolf, D., Nan, X., Bird, A.P. and Kouzarides, T. (2003) The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem., 278, 4035-4040.
36. Ghoshal, K., Datta, J., Majumder, S., Bai, S., Dong, X., Parthun, M. and Jacob, S.T. (2002) Inhibitors of histone deacetylase and DNA methyl-transferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure. Mol. Cell. Biol., 22, 8302-8319.
37. Koizume, S., Tachibana, K., Sekiya, T., Hirohashi, S. and Shiraishi, M. (2002) Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells. Nucl. Acids Res., 30, 4770-4780.
38. Lunyak, V.V., Burgess, R., Prefontaine, G.G., Nelson, C., Sze, S.H., Chenoweth, J., Schwartz, P., Pevzner, P.A., Glass, C., Mandel, G. and Rosenfeld, M.G. (2002) Corepressor-dependent silencing of chromosomal regions encoding neuronal genes. Science, 298, 1747-1752.
39. El Osta, A., Kantharidis, P., Zalcberg, J.R. and Wolffe, A.P. (2002) Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation. Mol. Cell. Biol., 22, 1844-1857.
40. Nguyen, C.T., Gonzales, F.A. and Jones, P.A. (2001) Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucl. Acids Res., 29, 4598-4606.
41. Ballestar, E., Yusufzai, T.M. and Wolffe, A.P. (2000) Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. Biochemistry, 39, 7100-7106.
42. Yusufzai, T.M. and Wolffe, A.P. (2000) Functional consequences of Rett syndrome mutations on human MeCP2. Nucl. Acids Res., 28, 4172-4179.
43. Free, A., Wakefield, R.I., Smith, B.O., Dryden, D.T., Barlow, P.N. and Bird, A.P. (2001) DNA recognition by the methyl-CpG binding domain of MeCP2. J. Biol. Chem., 276, 3353-3360.
44. Meehan, R.R., Lewis, J.D. and Bird, A.P. (1992) Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucl. Acids Res., 20, 5085-5092.
45. Nan, X., Campoy, F.J. and Bird, A. (1997) MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell, 88, 471-481.
46. Nan, X., Ng, H.H., Johnson, C.A., Laherty, C.D., Turner, B.M., Eisemnan, R.N. and Bird, A. (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature, 393, 386-389.
47. Jones, P.L., Veenstra, G.J., Wade, P.A., Vermaak, D., Kass, S.U., Landsberger, N., Strouboulis, J. and Wolffe, A.P. (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet., 19, 187-191.
48. Kaludov, N.K. and Wolffe, A.P. (2000) MeCP2 driven transcriptional repression in vitro: selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery. Nucl. Acids Res., 28, 1921-1928.
49. Kimura, H. and Shiota, K. (2003) Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1. J. Biol. Chem., 278, 4806-4812.
50. Kokura, K., Kaul, S.C., Wadhwa, R., Nomura, T., Khan, M.M., Shinagawa, T., Yasukawa, T., Colmenares, C. and Ishii, S. (2001) The Ski protein family is required for MeCP2-mediated transcriptional repression. J. Biol. Chem., 276, 34115-34121.
51. Tate, P., Skarnes, W. and Bird, A. (1996) The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse. Nat. Genet., 12, 205-208.
52. Guy, J., Hendrich, B., Holmes, M., Martin, J.E. and Bird, A. (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet., 27, 322-326.
53. Chen, R.Z., Akbarian, S., Tudor, M. and Jaenisch, R. (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet., 27, 327-331.
54. Zimmerman, L., Parr, B., Lendahl, U., Cunningham, M., McKay, R., Gavin, B., Mann, J., Vassileva, G. and McMahon, A. (1994) Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron, 12, 11-24.
55. Tsien, J.Z., Chen, D.F., Gerber, D., Tom, C., Mercer, E.H., Anderson, D.J., Mayford, M., Kandel, E.R. and Tonegawa, S. (1996) Subregion- and cell type-restricted gene knockout in mouse brain. Cell, 87, 1317-1326.
56. Colvin, L., Fyfe, S., Leonard, S., Schiavello, T., Ellaway, C., De Klerk, N., Christodoulou, J., Msall, M. and Leonard, H. (2003) Describing the phenotype in Rett syndrome using a population database. Arch. Dis. Child, 88, 38-43.
57. Nielsen, J.B., Henriksen, K.F., Hansen, C., Silahtaroglu, A., Schwartz, M. and Tommerup, N. (2001) MECP2 mutations in Danish patients with Rett syndrome: high frequency of mutations but no consistent correlations with clinical severity or with the X chromosome inactivation pattern. Eur. J. Hum. Genet., 9, 178-184.
58. Amir, R.E. and Zoghbi, H.Y. (2000) Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations. Am. J. Med. Genet., 97, 147-152.
59. Cheadle, J.P., Gill, H., Fleming, N., Maynard, J., Kerr, A., Leonard, H., Krawczak, M., Cooper, D.N., Lynch, S., Thomas, N. et al. (2000) Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum. Mol. Genet., 9, 1119-1129.
60. Hoffbuhr, K.C., Moses, L.M., Jerdonek, M.A., Naidu, S. and Hoffman, E.P. (2002) Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype. Ment. Retard. Dev. Disabil. Res. Rev., 8, 99-105.
61. Shahbazian, M., Young, J., Yuva-Paylor, L., Spencer, C., Antalffy, B., Noebels, J., Armstrong, D., Paylor, R. and Zoghbi, H. (2002) Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron, 35, 243-254.
62. Balmer, D., Goldstine, J., Rao, Y.M. and LaSalle, J.M. (2003) Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation. J. Mol. Med., 81, 61-68.
63. Shahbazian, M.D., Antalffy, B., Armstrong, D.L. and Zoghbi, H.Y. (2002) Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet., 11, 115-124.
64. Jung, B.P., Jugloff, D.G., Zhang, G., Logan, R., Brown, S. and Eubanks, J.H. (2003) The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells. J. Neurobiol., 55, 86-96.
65. Akbarian, S., Chen, R.Z., Gribnau, J., Rasmussen, T.P., Fong, H., Jaenisch, R. and Jones, E.G. (2001) Expression pattern of the Rett syndrome gene MeCP2 in primate prefrontal cortex. Neurobiol. Dis., 8, 784-791.
66. Cohen, D.R., Matarazzo, V., Palmer, A.M., Tu, Y., Jeon, O.H., Pevsner, J. and Ronnett, G.V. (2003) Expression of MeCP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis. Mol. Cell Neurosci., 22, 417-429.
67. Payen, E., Verkerk, T., Michalovich, D., Dreyer, S.D., Winterpacht, A., Lee, B., De Zeeuw, C.I., Grosveld, F. and Galjart, N. (1998) The centromeric/nucleolar chromatin protein ZFP-37 may function to specify neuronal nuclear domains. J. Biol. Chem., 273, 9099-9109.
68. Akhmanova, A., Verkerk, T., Langeveld, A., Grosveld, F. and Galjart, N. (2000) Characterisation of transcriptionally active and inactive chromatin domains in neurons. J. Cell Sci., 113 (Pt 24), 4463-4474.
69. Tudor, M., Akbarian, S., Chen, R.Z. and Jaenisch, R. (2002) Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc. Natl Acad. Sci. USA, 99, 15536-15541.
70. Nisenbaum, L.K. (2002) The ultimate chip shot: can microarray technology deliver for neuroscience? Genes Brain Behav., 1, 27-34.
71. Stancheva, I., Collins, A.L., Van den Veyver, I.B., Zoghbi, H. and Meehan, R. (2003) A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by Notch in Xenopus embryos. Mol. Cell, 12, 425-435.
72. Hendrich, B., Guy, J., Ramsahoye, B., Wilson, V.A. and Bird, A. (2001) Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes Dev., 15, 710-723.
73. Zhao, X., Ueba, T., Christie, B.R., Barkho, B., McConnell, M.J., Nakashima, K., Lein, E.S., Eadie, B.D., Willhoite, A.R., Muotri, A.R. et al. (2003) Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function. Proc. Natl Acad. Sci. USA, 100, 6777-6782.
74. Li, E., Bestor, T.H. and Jaenisch, R. (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell, 69, 915-926.
75. Fan, G., Beard, C., Chen, R.Z., Csankovszki, G., Sun, Y., Siniaia, M., Biniszkiewicz, D., Bates, B., Lee, P.P., Kuhn, R. et al. (2001) DNA hypomethylation perturbs the function and survival of CNS neurons in postnatal animals. J. Neurosci., 21, 788-797.
76. Hutchins, A.S., Mullen, A.C., Lee, H.W., Sykes, K.J., High, F.A., Hendrich, B.D., Bird, A.P. and Reiner, S.L. (2002) Gene silencing quantitatively controls the function of a developmental trans-activator. Mol. Cell, 10, 81-91.
77. Guan, Z., Giustetto, M., Lomvardas, S., Kim, J.H., Miniaci, M.C., Schwartz, J.H., Thanos, D. and Kandel, E.R. (2002) Integration of long-term-memory-related synaptic plasticity involves bidirectional regulation of gene expression and chromatin structure. Cell, 111, 483-493.
78. Ahmad, K. and Henikoff, S. (2002) Epigenetic consequences of nucleosome dynamics. Cell, 111, 281-284.